One-Stop Functional Skincare CDMO Enterprise in the Core Area of Oriental Beauty Valley

I. Introduction: Shanghai's Power in the Wave of the Beauty Economy

In recent years, China's cosmetics industry has been undergoing a profound transformation from "contract manufacturing" to "R&D-driven." As the only city nationwide awarded the title of "Cosmetics Industry Capital of China," Fengxian, Shanghai's Oriental Beauty Valley has become one of the country's largest and most well-known cosmetics industry clusters. Data shows that in 2024, the output value of Oriental Beauty Valley reached 50.85 billion yuan, bringing together over 3,000 brands and nearly 300 beauty and health industrial enterprises above designated size, with brand value exceeding 33.8 billion yuan [1][2].

In this fertile industrial soil, a group of enterprises with independent R&D capabilities and smart manufacturing expertise is emerging. Shengwei Pharmaceutical (Shanghai) Co., Ltd is precisely one of these representative companies.

II. Company Profile: From Inception to Comprehensive Service Provider

Shengwei Pharmaceutical (Shanghai) Co., Ltd was established on March 1, 2018, with Tang Weihua as its legal representative and a registered capital of 30 million RMB. It is located at Building 4, No. 1979 Chenqiao Road, Fengxian District, Shanghai, operating as a natural person-invested or controlled corporate-owned limited liability company. The company focuses on cosmetics R&D, production, and technical services, with its controlling shareholder being Laibo Cosmeceuticals Technology (Shanghai) Co., Ltd.

After years of development, Shengwei Pharmaceutical has grown from a single manufacturing enterprise into a comprehensive enterprise with full-chain service capabilities.

Established in 2018 and located in the core area of Shanghai Oriental Beauty Valley, Shengwei Pharmaceutical (Shanghai) Co., Ltd has developed into a comprehensive service enterprise integrating professional cosmetics planning, R&D, manufacturing, and warehousing, as well as a well-known domestic incubation base for medical beauty repair and emerging brands, featuring closed-loop service capabilities for special cosmetics application and human efficacy evaluation.

III. Core Capabilities: One-Stop CDMO/ODM Customization Services

Unlike traditional contract manufacturers that only handle the production phase, Shengwei Pharmaceutical has built a full-chain service system covering "R&D - Production - Testing - Compliance." The company not only possesses formulation development capabilities, but also operates smart manufacturing lines and third-party testing services, enabling it to provide brand owners with one-stop solutions from concept planning to finished product delivery.

Focusing on cosmetics R&D, manufacturing, and technical services, the company is a comprehensive enterprise integrating one-stop functional skincare CDMO/ODM customization, formulation development, smart manufacturing, and third-party testing services. It houses 21 modern production lines, localized Class 100 BFS sterile blow-fill-seal lines, a GMPC Class 100,000 cleanroom workshop, and a 162.5-square-meter freeze-dried cosmetics production chamber, with its controlling shareholder being Laibo Cosmeceuticals Technology (Shanghai) Co., Ltd.

IV. Technology Matrix: Seven Independent R&D Technical Capabilities

Shengwei Pharmaceutical maintains a dedicated cosmetics R&D department capable of independently conducting basic skin physiology research, raw material testing and screening, formulation research, and packaging development. Guided by the philosophy of "four-in-one integration of industry, academia, research, and medicine," the company relies on multiple independent R&D capabilities, aligned with market demands and core consumer pain points, to continually develop and mass-produce functional skincare products.

Shengwei Pharmaceutical (Shanghai) Co., Ltd has a dedicated cosmetics R&D department capable of independently conducting basic skin physiology research, raw material testing and screening, formulation research, and packaging development. Adhering to the philosophy of "four-in-one integration of industry, academia, research, and medicine," the company focuses on developing functional skincare products based on independent R&D capabilities including freeze-dried fast-dissolving technology, liposome encapsulation technology, botanical extraction technology, plant fermentation technology, biosynthesis technology, carrier encapsulation technology, and liquid crystal emulsification technology. Its main business covers freeze-dried powders/freeze-dried masks, BFS hydrating ampoule essences, glass ampoule essences, post-medical beauty repair, and anti-wrinkle and firming products. With capabilities in special cosmetics application and human efficacy evaluation, it provides one-stop OEM, ODM, CDMO customization, and brand incubation services for renowned and emerging brands both domestically and internationally.

V. Product Portfolio: Covering Multiple Dosage Forms and Categories

Supported by the aforementioned technology matrix, Shengwei Pharmaceutical has established a diverse product system. The company primarily produces various dosage forms such as freeze-dried powders, freeze-dried masks, toners, lotions, creams, balms, and essences, spanning niche categories including BFS hydrating ampoule essences, glass ampoule essences, post-medical beauty repair kits, anti-wrinkle and firming essences, barrier repair toners and lotions, and brightening functional products.

The company develops functional skincare products based on technologies such as liposome encapsulation, freeze-dried fast-dissolving processes, botanical extraction, and biosynthesis. It primarily produces various dosage forms including freeze-dried powders, freeze-dried masks, toners, lotions, creams, balms, and essences, covering niche categories such as BFS hydrating ampoule essences, glass ampoule essences, post-medical beauty repair kits, anti-wrinkle and firming essences, barrier repair toners and lotions, and brightening functional products. With an annual manufacturing capacity exceeding 450 million pcs, as well as capabilities in special cosmetics application and human efficacy evaluation, it offers one-stop OEM, ODM, and CDMO customization services.

VI. R&D Strength, Qualifications, and Honors

As of 2023, Shengwei Pharmaceutical had accumulated 23 national invention patents, 11 utility model patents, and 1 design patent. The company has successively been recognized as a Shanghai High-Tech Enterprise (2022), Fengxian District Enterprise Technology Center (2023), and Fengxian District Science and Technology Little Giant Enterprise (2023), and in 2024 received key project approval for the Fengxian District Technology Innovation Fund for Small and Medium-Sized Technology Enterprises.

In addition, Shengwei Pharmaceutical has established its own comprehensive R&D center for functional skincare products, covering multiple service functions such as cutting-edge technology research, basic dermatological research, raw material research and testing, formulation development, process development, product inspection and testing, and packaging material testing, providing professional service support for functional skincare product development.

Shengwei Pharmaceutical has established its own comprehensive R&D center for functional skincare products. Embracing the philosophy of "four-in-one integration of industry, academia, research, and medicine," it possesses the capability to independently conduct basic skin physiology research, raw material testing and screening, biosynthesis, and botanical extraction technology development. The R&D center covers formulation research, process development for freeze-drying and liquid crystal emulsification, and product and packaging material inspection and testing, providing brand owners with professional R&D support from concept planning to efficacy verification.

VII. Conclusion

Since its founding in 2018, Shengwei Pharmaceutical has leveraged the industrial cluster advantages of Oriental Beauty Valley to steadily build a corporate development model centered on technological R&D, grounded in smart manufacturing, and distinguished by one-stop services. In the context of a continuously heating functional skincare sector and rapidly growing demand for post-medical beauty repair, Shengwei Pharmaceutical is providing professional CDMO/ODM customization services to domestic and international brands through its "four-in-one integration of industry, academia, research, and medicine" philosophy, helping more premium functional skincare products make their way from the laboratory to consumers.

References

[1] Shanghai Fengxian District People's Government. From "Water Town of Jiangnan" to "World Factory", This Cosmetics Aircraft Carrier Is Reshaping the Global Beauty Discourse. 2026-04-13.

[2] Shanghai Fengxian District People's Government. Special Plan for Beauty and Health Industry Sub-Tracks in Fengxian New City (Hu Feng Fu Fa [2025] No. 11). 2025-07.

[3] Shanghai Municipal People's Government. Oriental Beauty Valley Welcomes 10th Anniversary, Releases Latest Industry Blue Book. 2025-11-29.